Perrigo (PRGO) Deferred Taxes (2013 - 2026)
Perrigo (PRGO) posted quarterly Deferred Taxes of -$12.9 million for Q1 2026, down 316.13% year-over-year from $6.0 million in Q1 2025, and up 64.95% quarter-over-quarter from -$36.8 million in Q4 2025.
Perrigo (PRGO) Deferred Taxes (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Deferred Taxes for 14 consecutive years, with -$12.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Deferred Taxes fell 316.13% year-over-year to -$12.9 million; the TTM figure through Mar 2026 stood at -$60.6 million (down 442.37% YoY), while the FY2025 annual figure was -$50.8 million, down 618.37% from the prior year.
- Deferred Taxes improved to -$12.9 million in Q1 2026 per PRGO's latest filing, from -$36.8 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $23.3 million in Q4 2024 and bottomed at -$118.9 million in Q4 2023.
- Historically, Deferred Taxes has averaged -$12.4 million across 5 years, with a median of -$9.9 million in 2023.
- On a YoY basis, Deferred Taxes climbed as much as 314.29% in 2022 and fell as far as 2400.0% in 2022.
- Perrigo's Deferred Taxes stood at -$30.9 million in 2022, then tumbled by 284.79% to -$118.9 million in 2023, then surged by 119.6% to $23.3 million in 2024, then plunged by 257.94% to -$36.8 million in 2025, then jumped by 64.95% to -$12.9 million in 2026.
- Business Quant data shows PRGO's Deferred Taxes at -$12.9 million in Q1 2026, -$36.8 million in Q4 2025, and -$23.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.16 Bn | 43.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.86 Bn | 40.20 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.53 Bn | 30.86 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.34 Bn | 19.68 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.89 Bn | 18.00 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -6.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -6.40 Mn |
| Mar 28, 2026 | -12.90 Mn |
| Dec 31, 2025 | -36.80 Mn |
| Sep 27, 2025 | -23.60 Mn |
| Jun 28, 2025 | 12.70 Mn |
| Mar 29, 2025 | -3.10 Mn |
| Dec 31, 2024 | 23.30 Mn |
| Sep 28, 2024 | -14.80 Mn |
| Jun 29, 2024 | 12.30 Mn |
| Mar 30, 2024 | -11.00 Mn |
| Dec 31, 2023 | -118.90 Mn |
| Sep 30, 2023 | 14.10 Mn |
| Jul 1, 2023 | 8.10 Mn |
| Apr 1, 2023 | -9.90 Mn |
| Dec 31, 2022 | -30.90 Mn |
| Oct 1, 2022 | -32.20 Mn |
| Jul 2, 2022 | 7.50 Mn |
| Apr 2, 2022 | 5.10 Mn |
| Dec 31, 2021 | 33.40 Mn |
| Oct 2, 2021 | 1.40 Mn |